Industry Research Reports
Part 1
Part 2
Part 3
Part 4
Part 5
Home > Reports > Service & Software > Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Description
The global market for Chemical API CDMO was estimated to be worth US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Chemical API CDMO, or Contract Research and Manufacturing Organization, provides pharmaceutical companies with customized R&D and manufacturing services for active pharmaceutical ingredients (APIs) and related intermediates from preclinical to commercialization stages. Its services encompass process route development and optimization, analytical method establishment and validation, pilot-scale and intermediate-scale production, process safety assessment, and support for large-scale production and registration applications in compliance with Good Manufacturing Practices (GMP). This model, through specialized division of labor, helps clients reduce R&D costs, shorten development cycles, address the challenges of complex chemical synthesis and production scale-up, and ensure supply chain reliability and compliance. It is a key enabling link in the supply chain for innovative chemical drugs and complex generic drugs.
Chemical API CDMO Market Size(US$)
M= millions and B=billions
The cost structure of a Chemical API CDMO primarily includes human resources investment in R&D and process optimization, depreciation and energy consumption of GMP-compliant production facilities, procurement of key materials, and strict environmental and quality control costs. Its gross profit margin typically ranges from 25% to 45%, depending on the complexity of the technology, production scale, and capacity utilization. Projects with technological barriers, such as highly active APIs and continuous flow processes, can command significant premiums, while standardized products produced at scale rely on cost control and supply chain efficiency to maintain profits.
The global landscape of Chemical API CDMO presents a "dual-core, diversified evolution" pattern. The Asia-Pacific region, represented by China and India, is the world's largest production capacity center and supply chain hub. Leveraging its mature chemical engineering foundation, cost advantages, and continuously improving compliance levels, it dominates the mid-to-back-end large-scale production market. Europe and North America maintain technological leadership in cutting-edge process development, complex molecule production, and early-stage clinical projects, particularly in the high-activity, high-value-added API sector. Currently, the global industrial chain is undergoing rapid restructuring. The need for supply chain security and regional autonomy is driving a trend towards decentralized and near-shore production capacity. Meanwhile, technological innovations such as green chemistry and continuous manufacturing, along with regulatory upgrades in emerging markets, are jointly shaping a more resilient, efficient, and sustainable new industry ecosystem for the future.
This report aims to provide a comprehensive presentation of the global market for Chemical API CDMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Chemical API CDMO by region & country, by Type, and by Application.
The Chemical API CDMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical API CDMO.
Market Segmentation
Report Metric
Details
Report Title
Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 43109 million
CAGR(2025-2031)
7.6%
Market Size Available for Years
2025-2031
Global Chemical API CDMO Companies Covered
Flamma Group
HAS Healthcare
Asymchem
Recipharm
Pierre Fabre
Pfizer CentreOne
Axplora
Lonza
MAI CDMO
BioVectra
Curia
AGC Pharma Chemicals
Asymchem
Olon Group
Evonik Health Care
Teva Active Pharmaceutical Ingredients
Global Chemical API CDMO Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chemical API CDMO Market, Segment by Type
Small Molecule CDMO
Macromolecule CDMO
Cell Gene Therapy (CGT) CDMO
Global Chemical API CDMO Market, Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Product Category
Early-stage R&D CDMO
Clinical Stage CDMO
Commercial Production CDMO
Market Segment
Bulk/Standard API CDMO
Specialty API CDMO
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chemical API CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Chemical API CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Chemical API CDMO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Chemical API CDMO Product Introduction
1.2 Global Chemical API CDMO Market Size Forecast (2020-2031)
1.3 Chemical API CDMO Market Trends & Drivers
1.3.1 Chemical API CDMO Industry Trends
1.3.2 Chemical API CDMO Market Drivers & Opportunity
1.3.3 Chemical API CDMO Market Challenges
1.3.4 Chemical API CDMO Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chemical API CDMO Players Revenue Ranking (2024)
2.2 Global Chemical API CDMO Revenue by Company (2020-2025)
2.3 Key Companies Chemical API CDMO Manufacturing Base Distribution and Headquarters
2.4 Key Companies Chemical API CDMO Product Offered
2.5 Key Companies Time to Begin Mass Production of Chemical API CDMO
2.6 Chemical API CDMO Market Competitive Analysis
2.6.1 Chemical API CDMO Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Chemical API CDMO Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical API CDMO as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Small Molecule CDMO
3.1.2 Macromolecule CDMO
3.1.3 Cell Gene Therapy (CGT) CDMO
3.2 Global Chemical API CDMO Sales Value by Type
3.2.1 Global Chemical API CDMO Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Chemical API CDMO Sales Value, by Type (2020-2031)
3.2.3 Global Chemical API CDMO Sales Value, by Type (%) (2020-2031)
4 Segmentation by Business Stage
4.1 Introduction by Business Stage
4.1.1 Early-stage R&D CDMO
4.1.2 Clinical Stage CDMO
4.1.3 Commercial Production CDMO
4.2 Global Chemical API CDMO Sales Value by Business Stage
4.2.1 Global Chemical API CDMO Sales Value by Business Stage (2020 VS 2024 VS 2031)
4.2.2 Global Chemical API CDMO Sales Value, by Business Stage (2020-2031)
4.2.3 Global Chemical API CDMO Sales Value, by Business Stage (%) (2020-2031)
5 Segmentation by Product Technology
5.1 Introduction by Product Technology
5.1.1 Bulk/Standard API CDMO
5.1.2 Specialty API CDMO
5.2 Global Chemical API CDMO Sales Value by Product Technology
5.2.1 Global Chemical API CDMO Sales Value by Product Technology (2020 VS 2024 VS 2031)
5.2.2 Global Chemical API CDMO Sales Value, by Product Technology (2020-2031)
5.2.3 Global Chemical API CDMO Sales Value, by Product Technology (%) (2020-2031)
6 Segmentation by Application
6.1 Introduction by Application
6.1.1 Pharmaceutical and Biotechnology Companies
6.1.2 Research and Academic Institutions
6.1.3 Hospital
6.1.4 Others
6.2 Global Chemical API CDMO Sales Value by Application
6.2.1 Global Chemical API CDMO Sales Value by Application (2020 VS 2024 VS 2031)
6.2.2 Global Chemical API CDMO Sales Value, by Application (2020-2031)
6.2.3 Global Chemical API CDMO Sales Value, by Application (%) (2020-2031)
7 Segmentation by Region
7.1 Global Chemical API CDMO Sales Value by Region
7.1.1 Global Chemical API CDMO Sales Value by Region: 2020 VS 2024 VS 2031
7.1.2 Global Chemical API CDMO Sales Value by Region (2020-2025)
7.1.3 Global Chemical API CDMO Sales Value by Region (2026-2031)
7.1.4 Global Chemical API CDMO Sales Value by Region (%), (2020-2031)
7.2 North America
7.2.1 North America Chemical API CDMO Sales Value, 2020-2031
7.2.2 North America Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
7.3 Europe
7.3.1 Europe Chemical API CDMO Sales Value, 2020-2031
7.3.2 Europe Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
7.4 Asia Pacific
7.4.1 Asia Pacific Chemical API CDMO Sales Value, 2020-2031
7.4.2 Asia Pacific Chemical API CDMO Sales Value by Region (%), 2024 VS 2031
7.5 South America
7.5.1 South America Chemical API CDMO Sales Value, 2020-2031
7.5.2 South America Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
7.6 Middle East & Africa
7.6.1 Middle East & Africa Chemical API CDMO Sales Value, 2020-2031
7.6.2 Middle East & Africa Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
8 Segmentation by Key Countries/Regions
8.1 Key Countries/Regions Chemical API CDMO Sales Value Growth Trends, 2020 VS 2024 VS 2031
8.2 Key Countries/Regions Chemical API CDMO Sales Value, 2020-2031
8.3 United States
8.3.1 United States Chemical API CDMO Sales Value, 2020-2031
8.3.2 United States Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
8.3.3 United States Chemical API CDMO Sales Value by Application, 2024 VS 2031
8.4 Europe
8.4.1 Europe Chemical API CDMO Sales Value, 2020-2031
8.4.2 Europe Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
8.4.3 Europe Chemical API CDMO Sales Value by Application, 2024 VS 2031
8.5 China
8.5.1 China Chemical API CDMO Sales Value, 2020-2031
8.5.2 China Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
8.5.3 China Chemical API CDMO Sales Value by Application, 2024 VS 2031
8.6 Japan
8.6.1 Japan Chemical API CDMO Sales Value, 2020-2031
8.6.2 Japan Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
8.6.3 Japan Chemical API CDMO Sales Value by Application, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Chemical API CDMO Sales Value, 2020-2031
8.7.2 South Korea Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
8.7.3 South Korea Chemical API CDMO Sales Value by Application, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Chemical API CDMO Sales Value, 2020-2031
8.8.2 Southeast Asia Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
8.8.3 Southeast Asia Chemical API CDMO Sales Value by Application, 2024 VS 2031
8.9 India
8.9.1 India Chemical API CDMO Sales Value, 2020-2031
8.9.2 India Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
8.9.3 India Chemical API CDMO Sales Value by Application, 2024 VS 2031
9 Company Profiles
9.1 Flamma Group
9.1.1 Flamma Group Profile
9.1.2 Flamma Group Main Business
9.1.3 Flamma Group Chemical API CDMO Products, Services and Solutions
9.1.4 Flamma Group Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.1.5 Flamma Group Recent Developments
9.2 HAS Healthcare
9.2.1 HAS Healthcare Profile
9.2.2 HAS Healthcare Main Business
9.2.3 HAS Healthcare Chemical API CDMO Products, Services and Solutions
9.2.4 HAS Healthcare Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.2.5 HAS Healthcare Recent Developments
9.3 Asymchem
9.3.1 Asymchem Profile
9.3.2 Asymchem Main Business
9.3.3 Asymchem Chemical API CDMO Products, Services and Solutions
9.3.4 Asymchem Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.3.5 Asymchem Recent Developments
9.4 Recipharm
9.4.1 Recipharm Profile
9.4.2 Recipharm Main Business
9.4.3 Recipharm Chemical API CDMO Products, Services and Solutions
9.4.4 Recipharm Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.4.5 Recipharm Recent Developments
9.5 Pierre Fabre
9.5.1 Pierre Fabre Profile
9.5.2 Pierre Fabre Main Business
9.5.3 Pierre Fabre Chemical API CDMO Products, Services and Solutions
9.5.4 Pierre Fabre Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.5.5 Pierre Fabre Recent Developments
9.6 Pfizer CentreOne
9.6.1 Pfizer CentreOne Profile
9.6.2 Pfizer CentreOne Main Business
9.6.3 Pfizer CentreOne Chemical API CDMO Products, Services and Solutions
9.6.4 Pfizer CentreOne Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.6.5 Pfizer CentreOne Recent Developments
9.7 Axplora
9.7.1 Axplora Profile
9.7.2 Axplora Main Business
9.7.3 Axplora Chemical API CDMO Products, Services and Solutions
9.7.4 Axplora Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.7.5 Axplora Recent Developments
9.8 Lonza
9.8.1 Lonza Profile
9.8.2 Lonza Main Business
9.8.3 Lonza Chemical API CDMO Products, Services and Solutions
9.8.4 Lonza Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.8.5 Lonza Recent Developments
9.9 MAI CDMO
9.9.1 MAI CDMO Profile
9.9.2 MAI CDMO Main Business
9.9.3 MAI CDMO Chemical API CDMO Products, Services and Solutions
9.9.4 MAI CDMO Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.9.5 MAI CDMO Recent Developments
9.10 BioVectra
9.10.1 BioVectra Profile
9.10.2 BioVectra Main Business
9.10.3 BioVectra Chemical API CDMO Products, Services and Solutions
9.10.4 BioVectra Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.10.5 BioVectra Recent Developments
9.11 Curia
9.11.1 Curia Profile
9.11.2 Curia Main Business
9.11.3 Curia Chemical API CDMO Products, Services and Solutions
9.11.4 Curia Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.11.5 Curia Recent Developments
9.12 AGC Pharma Chemicals
9.12.1 AGC Pharma Chemicals Profile
9.12.2 AGC Pharma Chemicals Main Business
9.12.3 AGC Pharma Chemicals Chemical API CDMO Products, Services and Solutions
9.12.4 AGC Pharma Chemicals Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.12.5 AGC Pharma Chemicals Recent Developments
9.13 Asymchem
9.13.1 Asymchem Profile
9.13.2 Asymchem Main Business
9.13.3 Asymchem Chemical API CDMO Products, Services and Solutions
9.13.4 Asymchem Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.13.5 Asymchem Recent Developments
9.14 Olon Group
9.14.1 Olon Group Profile
9.14.2 Olon Group Main Business
9.14.3 Olon Group Chemical API CDMO Products, Services and Solutions
9.14.4 Olon Group Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.14.5 Olon Group Recent Developments
9.15 Evonik Health Care
9.15.1 Evonik Health Care Profile
9.15.2 Evonik Health Care Main Business
9.15.3 Evonik Health Care Chemical API CDMO Products, Services and Solutions
9.15.4 Evonik Health Care Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.15.5 Evonik Health Care Recent Developments
9.16 Teva Active Pharmaceutical Ingredients
9.16.1 Teva Active Pharmaceutical Ingredients Profile
9.16.2 Teva Active Pharmaceutical Ingredients Main Business
9.16.3 Teva Active Pharmaceutical Ingredients Chemical API CDMO Products, Services and Solutions
9.16.4 Teva Active Pharmaceutical Ingredients Chemical API CDMO Revenue (US$ Million) & (2020-2025)
9.16.5 Teva Active Pharmaceutical Ingredients Recent Developments
10 Industry Chain Analysis
10.1 Chemical API CDMO Industrial Chain
10.2 Chemical API CDMO Upstream Analysis
10.2.1 Key Raw Materials
10.2.2 Raw Materials Key Suppliers
10.2.3 Manufacturing Cost Structure
10.3 Midstream Analysis
10.4 Downstream Analysis (Customers Analysis)
10.5 Sales Model and Sales Channels
10.5.1 Chemical API CDMO Sales Model
10.5.2 Sales Channel
10.5.3 Chemical API CDMO Distributors
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Chemical API CDMO Market Trends
Table 2. Chemical API CDMO Market Drivers & Opportunity
Table 3. Chemical API CDMO Market Challenges
Table 4. Chemical API CDMO Market Restraints
Table 5. Global Chemical API CDMO Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Chemical API CDMO Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Chemical API CDMO Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Chemical API CDMO Product Type
Table 9. Key Companies Time to Begin Mass Production of Chemical API CDMO
Table 10. Global Chemical API CDMO Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical API CDMO as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Chemical API CDMO Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Chemical API CDMO Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Chemical API CDMO Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Chemical API CDMO Sales Market Share in Value by Type (2020-2025)
Table 17. Global Chemical API CDMO Sales Market Share in Value by Type (2026-2031)
Table 18. Global Chemical API CDMO Sales Value by Business Stage: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Chemical API CDMO Sales Value by Business Stage (2020-2025) & (US$ Million)
Table 20. Global Chemical API CDMO Sales Value by Business Stage (2026-2031) & (US$ Million)
Table 21. Global Chemical API CDMO Sales Market Share in Value by Business Stage (2020-2025)
Table 22. Global Chemical API CDMO Sales Market Share in Value by Business Stage (2026-2031)
Table 23. Global Chemical API CDMO Sales Value by Product Technology: 2020 VS 2024 VS 2031 (US$ Million)
Table 24. Global Chemical API CDMO Sales Value by Product Technology (2020-2025) & (US$ Million)
Table 25. Global Chemical API CDMO Sales Value by Product Technology (2026-2031) & (US$ Million)
Table 26. Global Chemical API CDMO Sales Market Share in Value by Product Technology (2020-2025)
Table 27. Global Chemical API CDMO Sales Market Share in Value by Product Technology (2026-2031)
Table 28. Global Chemical API CDMO Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Chemical API CDMO Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Chemical API CDMO Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Chemical API CDMO Sales Market Share in Value by Application (2020-2025)
Table 32. Global Chemical API CDMO Sales Market Share in Value by Application (2026-2031)
Table 33. Global Chemical API CDMO Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 34. Global Chemical API CDMO Sales Value by Region (2020-2025) & (US$ Million)
Table 35. Global Chemical API CDMO Sales Value by Region (2026-2031) & (US$ Million)
Table 36. Global Chemical API CDMO Sales Value by Region (2020-2025) & (%)
Table 37. Global Chemical API CDMO Sales Value by Region (2026-2031) & (%)
Table 38. Key Countries/Regions Chemical API CDMO Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 39. Key Countries/Regions Chemical API CDMO Sales Value, (2020-2025) & (US$ Million)
Table 40. Key Countries/Regions Chemical API CDMO Sales Value, (2026-2031) & (US$ Million)
Table 41. Flamma Group Basic Information List
Table 42. Flamma Group Description and Business Overview
Table 43. Flamma Group Chemical API CDMO Products, Services and Solutions
Table 44. Revenue (US$ Million) in Chemical API CDMO Business of Flamma Group (2020-2025)
Table 45. Flamma Group Recent Developments
Table 46. HAS Healthcare Basic Information List
Table 47. HAS Healthcare Description and Business Overview
Table 48. HAS Healthcare Chemical API CDMO Products, Services and Solutions
Table 49. Revenue (US$ Million) in Chemical API CDMO Business of HAS Healthcare (2020-2025)
Table 50. HAS Healthcare Recent Developments
Table 51. Asymchem Basic Information List
Table 52. Asymchem Description and Business Overview
Table 53. Asymchem Chemical API CDMO Products, Services and Solutions
Table 54. Revenue (US$ Million) in Chemical API CDMO Business of Asymchem (2020-2025)
Table 55. Asymchem Recent Developments
Table 56. Recipharm Basic Information List
Table 57. Recipharm Description and Business Overview
Table 58. Recipharm Chemical API CDMO Products, Services and Solutions
Table 59. Revenue (US$ Million) in Chemical API CDMO Business of Recipharm (2020-2025)
Table 60. Recipharm Recent Developments
Table 61. Pierre Fabre Basic Information List
Table 62. Pierre Fabre Description and Business Overview
Table 63. Pierre Fabre Chemical API CDMO Products, Services and Solutions
Table 64. Revenue (US$ Million) in Chemical API CDMO Business of Pierre Fabre (2020-2025)
Table 65. Pierre Fabre Recent Developments
Table 66. Pfizer CentreOne Basic Information List
Table 67. Pfizer CentreOne Description and Business Overview
Table 68. Pfizer CentreOne Chemical API CDMO Products, Services and Solutions
Table 69. Revenue (US$ Million) in Chemical API CDMO Business of Pfizer CentreOne (2020-2025)
Table 70. Pfizer CentreOne Recent Developments
Table 71. Axplora Basic Information List
Table 72. Axplora Description and Business Overview
Table 73. Axplora Chemical API CDMO Products, Services and Solutions
Table 74. Revenue (US$ Million) in Chemical API CDMO Business of Axplora (2020-2025)
Table 75. Axplora Recent Developments
Table 76. Lonza Basic Information List
Table 77. Lonza Description and Business Overview
Table 78. Lonza Chemical API CDMO Products, Services and Solutions
Table 79. Revenue (US$ Million) in Chemical API CDMO Business of Lonza (2020-2025)
Table 80. Lonza Recent Developments
Table 81. MAI CDMO Basic Information List
Table 82. MAI CDMO Description and Business Overview
Table 83. MAI CDMO Chemical API CDMO Products, Services and Solutions
Table 84. Revenue (US$ Million) in Chemical API CDMO Business of MAI CDMO (2020-2025)
Table 85. MAI CDMO Recent Developments
Table 86. BioVectra Basic Information List
Table 87. BioVectra Description and Business Overview
Table 88. BioVectra Chemical API CDMO Products, Services and Solutions
Table 89. Revenue (US$ Million) in Chemical API CDMO Business of BioVectra (2020-2025)
Table 90. BioVectra Recent Developments
Table 91. Curia Basic Information List
Table 92. Curia Description and Business Overview
Table 93. Curia Chemical API CDMO Products, Services and Solutions
Table 94. Revenue (US$ Million) in Chemical API CDMO Business of Curia (2020-2025)
Table 95. Curia Recent Developments
Table 96. AGC Pharma Chemicals Basic Information List
Table 97. AGC Pharma Chemicals Description and Business Overview
Table 98. AGC Pharma Chemicals Chemical API CDMO Products, Services and Solutions
Table 99. Revenue (US$ Million) in Chemical API CDMO Business of AGC Pharma Chemicals (2020-2025)
Table 100. AGC Pharma Chemicals Recent Developments
Table 101. Asymchem Basic Information List
Table 102. Asymchem Description and Business Overview
Table 103. Asymchem Chemical API CDMO Products, Services and Solutions
Table 104. Revenue (US$ Million) in Chemical API CDMO Business of Asymchem (2020-2025)
Table 105. Asymchem Recent Developments
Table 106. Olon Group Basic Information List
Table 107. Olon Group Description and Business Overview
Table 108. Olon Group Chemical API CDMO Products, Services and Solutions
Table 109. Revenue (US$ Million) in Chemical API CDMO Business of Olon Group (2020-2025)
Table 110. Olon Group Recent Developments
Table 111. Evonik Health Care Basic Information List
Table 112. Evonik Health Care Description and Business Overview
Table 113. Evonik Health Care Chemical API CDMO Products, Services and Solutions
Table 114. Revenue (US$ Million) in Chemical API CDMO Business of Evonik Health Care (2020-2025)
Table 115. Evonik Health Care Recent Developments
Table 116. Teva Active Pharmaceutical Ingredients Basic Information List
Table 117. Teva Active Pharmaceutical Ingredients Description and Business Overview
Table 118. Teva Active Pharmaceutical Ingredients Chemical API CDMO Products, Services and Solutions
Table 119. Revenue (US$ Million) in Chemical API CDMO Business of Teva Active Pharmaceutical Ingredients (2020-2025)
Table 120. Teva Active Pharmaceutical Ingredients Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Chemical API CDMO Downstream Customers
Table 124. Chemical API CDMO Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemical API CDMO Product Picture
Figure 2. Global Chemical API CDMO Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Chemical API CDMO Sales Value (2020-2031) & (US$ Million)
Figure 4. Chemical API CDMO Report Years Considered
Figure 5. Global Chemical API CDMO Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Chemical API CDMO Revenue in 2024
Figure 7. Chemical API CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Small Molecule CDMO Picture
Figure 9. Macromolecule CDMO Picture
Figure 10. Cell Gene Therapy (CGT) CDMO Picture
Figure 11. Global Chemical API CDMO Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Chemical API CDMO Sales Value Market Share by Type, 2024 & 2031
Figure 13. Early-stage R&D CDMO Picture
Figure 14. Clinical Stage CDMO Picture
Figure 15. Commercial Production CDMO Picture
Figure 16. Global Chemical API CDMO Sales Value by Business Stage (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Chemical API CDMO Sales Value Market Share by Business Stage, 2024 & 2031
Figure 18. Bulk/Standard API CDMO Picture
Figure 19. Specialty API CDMO Picture
Figure 20. Global Chemical API CDMO Sales Value by Product Technology (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Chemical API CDMO Sales Value Market Share by Product Technology, 2024 & 2031
Figure 22. Product Picture of Pharmaceutical and Biotechnology Companies
Figure 23. Product Picture of Research and Academic Institutions
Figure 24. Product Picture of Hospital
Figure 25. Product Picture of Others
Figure 26. Global Chemical API CDMO Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 27. Global Chemical API CDMO Sales Value Market Share by Application, 2024 & 2031
Figure 28. North America Chemical API CDMO Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Chemical API CDMO Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Chemical API CDMO Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Chemical API CDMO Sales Value (%), (2020-2031)
Figure 39. United States Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Chemical API CDMO Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Chemical API CDMO Sales Value by Application (%), 2024 VS 2031
Figure 45. China Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
Figure 47. China Chemical API CDMO Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Chemical API CDMO Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Chemical API CDMO Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Chemical API CDMO Sales Value by Application (%), 2024 VS 2031
Figure 57. India Chemical API CDMO Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Chemical API CDMO Sales Value by Type (%), 2024 VS 2031
Figure 59. India Chemical API CDMO Sales Value by Application (%), 2024 VS 2031
Figure 60. Chemical API CDMO Industrial Chain
Figure 61. Chemical API CDMO Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives InterviewedDescription
The global market for Chemical API CDMO was estimated to be worth US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Chemical API CDMO, or Contract Research and Manufacturing Organization, provides pharmaceutical companies with customized R&D and manufacturing services for active pharmaceutical ingredients (APIs) and related intermediates from preclinical to commercialization stages. Its services encompass process route development and optimization, analytical method establishment and validation, pilot-scale and intermediate-scale production, process safety assessment, and support for large-scale production and registration applications in compliance with Good Manufacturing Practices (GMP). This model, through specialized division of labor, helps clients reduce R&D costs, shorten development cycles, address the challenges of complex chemical synthesis and production scale-up, and ensure supply chain reliability and compliance. It is a key enabling link in the supply chain for innovative chemical drugs and complex generic drugs.
The cost structure of a Chemical API CDMO primarily includes human resources investment in R&D and process optimization, depreciation and energy consumption of GMP-compliant production facilities, procurement of key materials, and strict environmental and quality control costs. Its gross profit margin typically ranges from 25% to 45%, depending on the complexity of the technology, production scale, and capacity utilization. Projects with technological barriers, such as highly active APIs and continuous flow processes, can command significant premiums, while standardized products produced at scale rely on cost control and supply chain efficiency to maintain profits.
The global landscape of Chemical API CDMO presents a "dual-core, diversified evolution" pattern. The Asia-Pacific region, represented by China and India, is the world's largest production capacity center and supply chain hub. Leveraging its mature chemical engineering foundation, cost advantages, and continuously improving compliance levels, it dominates the mid-to-back-end large-scale production market. Europe and North America maintain technological leadership in cutting-edge process development, complex molecule production, and early-stage clinical projects, particularly in the high-activity, high-value-added API sector. Currently, the global industrial chain is undergoing rapid restructuring. The need for supply chain security and regional autonomy is driving a trend towards decentralized and near-shore production capacity. Meanwhile, technological innovations such as green chemistry and continuous manufacturing, along with regulatory upgrades in emerging markets, are jointly shaping a more resilient, efficient, and sustainable new industry ecosystem for the future.
This report aims to provide a comprehensive presentation of the global market for Chemical API CDMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Chemical API CDMO by region & country, by Type, and by Application.
The Chemical API CDMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical API CDMO.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chemical API CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Chemical API CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Chemical API CDMO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Chemical API CDMO was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 95
USD 3950.00
(Single User License)
Global Chemical API CDMO Market Research Report 2024
The global Chemical API CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 76
USD 2900.00
(Single User License)
Global Chemical API CDMO Market Research Report 2025
The global market for Chemical API CDMO was valued at US$ 25750 million in the year 2024 and is projected to reach a revised size of US$ 43109 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Published: 2025-12-12
Pages: 137
USD 2900.00
(Single User License)
Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chemical API CDMO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 92
USD 3950.00
(Single User License)
Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chemical API CDMO market is projected to grow from US$ 25750 million in 2024 to US$ 43109 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 152
USD 4900.00
(Single User License)
Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chemical API CDMO market size was US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 104
USD 4250.00
(Single User License)
Global Chemical API CDMO Market Research Report 2026
The global Chemical API CDMO market was valued at US$ 27700 million in 2025 and is anticipated to reach US$ 46080 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-01-15
Pages: 139
USD 2900.00
(Single User License)
Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chemical API CDMO was estimated to be worth US$ 27700 million in 2025 and is projected to reach US$ 46080 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-01-19
Pages: 125
USD 3950.00
(Single User License)
Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chemical API CDMO market size was US$ 27700 million in 2025 and is forecast to reach a readjusted size of US$ 46080 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 109
USD 4250.00
(Single User License)
Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chemical API CDMO market is projected to grow from US$ 27700 million in 2025 to US$ 46080 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 151
USD 4900.00
(Single User License)
Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Chemical API CDMO was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 95
USD 3950.00 ()Global Chemical API CDMO Market Research Report 2024
The global Chemical API CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-28
Pages: 76
USD 2900.00 ()Global Chemical API CDMO Market Research Report 2025
The global market for Chemical API CDMO was valued at US$ 25750 million in the year 2024 and is projected to reach a revised size of US$ 43109 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Published: 2025-12-12
Pages: 137
USD 2900.00 ()Chemical API CDMO- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chemical API CDMO was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 92
USD 3950.00 ()Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chemical API CDMO market is projected to grow from US$ 25750 million in 2024 to US$ 43109 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 152
USD 4900.00 ()Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chemical API CDMO market size was US$ 25750 million in 2024 and is forecast to a readjusted size of US$ 43109 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 104
USD 4250.00 ()Global Chemical API CDMO Market Research Report 2026
The global Chemical API CDMO market was valued at US$ 27700 million in 2025 and is anticipated to reach US$ 46080 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-01-15
Pages: 139
USD 2900.00 ()Chemical API CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chemical API CDMO was estimated to be worth US$ 27700 million in 2025 and is projected to reach US$ 46080 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-01-19
Pages: 125
USD 3950.00 ()Global Chemical API CDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chemical API CDMO market size was US$ 27700 million in 2025 and is forecast to reach a readjusted size of US$ 46080 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 109
USD 4250.00 ()Global Chemical API CDMO Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chemical API CDMO market is projected to grow from US$ 27700 million in 2025 to US$ 46080 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 151
USD 4900.00 ()
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Have a question?
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database